Affordable Care Act: Will it Matter If Coverage Is Affordable If There Are No Insurers to Buy it From?
This week’s BioBlog focuses on the landscape of the ACA after another insurer pulls out; the increase in Part D spending and; big data in cancer research.
“Aetna pulling out is like Lehman Brothers failing during the mortgage crisis. It is the bellwether that highlights the underlying fault line in the Affordable Care Act,” he told FierceHeathPayer in an email.
According to an analysis done for The Upshot by the McKinsey Center for U.S. Health System Reform, 17 percent of Americans eligible for an Affordable Care Act plan may have only one insurer to choose next year.
The newly insured filled, on average, 28 percent more prescriptions and had 29 percent less out-of-pocket spending per prescription in 2014 compared to 2013, finds a new study from Health Affairs.
CMS Chief Data Officer Niall Brennan said in a statement. “Today’s release joins a series of actions the Administration is taking to improve transparency around government data, including the cost of prescription drugs.”
In this editorial piece from Cancer Today, Editor-In-Chief William G. Nelson, MD, PhD shares his thoughts on the impact big data can have on the Cancer Moonshot initiative.